{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:09:17Z","timestamp":1789499357891,"version":"build-2803163510"},"reference-count":60,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.5551\/jat.57125","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T22:06:59Z","timestamp":1612303619000},"page":"200-220","source":"Crossref","is-referenced-by-count":45,"title":["MicroRNA-320b Modulates Cholesterol Efflux and Atherosclerosis"],"prefix":"10.5551","volume":"29","author":[{"given":"Xiaomei","family":"Lu","sequence":"first","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfan","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufeng","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfeng","family":"Lu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Gu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Yeboah J, Young R, McClelland RL, Delaney JC, Polonsky TS, Dawood FZ, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC, Jr., Psaty BM, Greenland P and Herrington DM. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. J Am Coll Cardiol, 2016; 67: 139-147","DOI":"10.1016\/j.jacc.2015.10.058"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tabas I and Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circ Res, 2016; 118: 653-667","DOI":"10.1161\/CIRCRESAHA.115.306256"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lusis AJ. Atherosclerosis. Nature, 2000; 407: 233-241","DOI":"10.1038\/35025203"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Yuan Y, Li P and Ye J. Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis. Protein Cell, 2012; 3: 173-181","DOI":"10.1007\/s13238-012-2025-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Zhao JF, Ching LC, Huang YC, Chen CY, Chiang AN, Kou YR, Shyue SK and Lee TS. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Mol Nutr Food Res, 2012; 56: 691-701","DOI":"10.1002\/mnfr.201100735"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, Rhee JS, Silverstein R, Hoff HF and Freeman MW. Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem, 2002; 277: 49982-49988","DOI":"10.1074\/jbc.M209649200"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Moore KJ and Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell, 2011; 145: 341-355","DOI":"10.1016\/j.cell.2011.04.005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) He J, Zhang G, Pang Q, Yu C, Xiong J, Zhu J and Chen F. SIRT6 reduces macrophage foam cell formation by inducing autophagy and cholesterol efflux under ox-LDL condition. FEBS J, 2017; 284: 1324-1337","DOI":"10.1111\/febs.14055"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tall AR, Yvan-Charvet L, Terasaka N, Pagler T and Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab, 2008; 7: 365-375","DOI":"10.1016\/j.cmet.2008.03.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ogura M, Ayaori M, Terao Y, Hisada T, Iizuka M, Takiguchi S, Uto-Kondo H, Yakushiji E, Nakaya K, Sasaki M, Komatsu T, Ozasa H, Ohsuzu F and Ikewaki K. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo.Arterioscl Throm Vas Biol, 2011; 31: 1980-1987","DOI":"10.1161\/ATVBAHA.111.228478"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Shridas P, Bailey WM, Gizard F, Oslund RC, Gelb MH, Bruemmer D and Webb NR. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.Arterioscl Throm Vas Biol, 2010; 30: 2014-2021","DOI":"10.1161\/ATVBAHA.110.210237"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yvan-Charvet L, Wang N and Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscl Throm Vas Biol, 2010; 30: 139-143","DOI":"10.1161\/ATVBAHA.108.179283"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Chellan B, Yan L, Sontag TJ, Reardon CA and Hofmann Bowman MA. IL-22 is induced by S100\/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1. J Lipid Res, 2014; 55: 443-454","DOI":"10.1194\/jlr.M044305"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Liang B, Wang X, Song X, Bai R, Yang H, Yang Z, Xiao C and Bian Y. MicroRNA-20a\/b regulates cholesterol efflux through post-transcriptional repression of ATP-binding cassette transporter A1. Biochim Biophys Acta Mol Cell Biol Lipids, 2017; 1862: 929-938","DOI":"10.1016\/j.bbalip.2017.06.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yang S, Ye ZM, Chen S, Luo XY, Chen SL, Mao L, Li Y, Jin H, Yu C, Xiang FX, Xie MX, Chang J, Xia YP and Hu B. MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1\/G1 in macrophages. J Mol Cell Cardiol, 2018; 123: 139-149","DOI":"10.1016\/j.yjmcc.2018.09.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zaiou M and Bakillah A. Epigenetic Regulation of ATP-Binding Cassette Protein A1 (ABCA1) Gene Expression: A New Era to Alleviate Atherosclerotic Cardiovascular Disease. Diseases, 2018; 6: 1-6","DOI":"10.3390\/diseases6020034"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Santamarina-Fojo S, Remaley AT, Neufeld EB and Brewer HB, Jr. Regulation and intracellular trafficking of the ABCA1 transporter. J Lipid Res, 2001; 42: 1339-1345","DOI":"10.1016\/S0022-2275(20)30266-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nelson JK. EEPD1 Is a Novel LXR Target Gene in Macrophages Which Regulates ABCA1 Abundance and Cholesterol Efflux. Arterioscler Thromb Vasc Biol, 2017; 37: 423-432","DOI":"10.1161\/ATVBAHA.116.308434"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nelson JK, Koenis DS, Scheij S, Cook EC, Moeton M, Santos A, Lobaccaro JA, Baron S and Zelcer N. EEPD1 Is a Novel LXR Target Gene in Macrophages Which Regulates ABCA1 Abundance and Cholesterol Efflux. Arterioscler Thromb Vasc Biol, 2017; 37: 423-432","DOI":"10.1161\/ATVBAHA.116.308434"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Geyeregger R, Zeyda M and Stulnig TM. Liver X receptors in cardiovascular and metabolic disease. Cell Mol Life Sci, 2006; 63: 524-539","DOI":"10.1007\/s00018-005-5398-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Yu XH, Fu YC, Zhang DW, Yin K and Tang CK. Foam cells in atherosclerosis. Clin Chim Acta, 2013; 424: 245-252","DOI":"10.1016\/j.cca.2013.06.006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Tontonoz P and Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol, 2003; 17: 985-993","DOI":"10.1210\/me.2003-0061"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) O\u2019Brien J, Hayder H, Zayed Y and Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne), 2018; 9: 402","DOI":"10.3389\/fendo.2018.00402"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Li J and Zhang S. microRNA-150 inhibits the formation of macrophage foam cells through targeting adiponectin receptor 2. Biochem Bioph Res Commun, 2016; 476: 218-224","DOI":"10.1016\/j.bbrc.2016.05.096"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Huang RS, Hu GQ, Lin B, Lin ZY and Sun CC. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med, 2010; 58: 961-967","DOI":"10.2310\/JIM.0b013e3181ff46d7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Chen KC and Juo SH. MicroRNAs in atherosclerosis. Kaohsiung J Med Sci, 2012; 28: 631-640","DOI":"10.1016\/j.kjms.2012.04.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Li CH, Gong D, Chen LY, Zhang M, Xia XD, Cheng HP, Huang C, Zhao ZW, Zheng XL, Tang XE and Tang CK. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages. Eur J Pharmacol, 2017; 811: 74-86","DOI":"10.1016\/j.ejphar.2017.05.055"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Wang D, Yan X, Xia M, Yang Y, Li D, Li X, Song F and Ling W. Coenzyme Q10 promotes macrophage cholesterol efflux by regulation of the activator protein-1\/miR-378\/ATP-binding cassette transporter G1-signaling pathway. Arterioscl Throm Vas Biol, 2014; 34: 1860-1870","DOI":"10.1161\/ATVBAHA.113.302879"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Gidlof O, van der Brug M, Ohman J, Gilje P, Olde B, Wahlestedt C and Erlinge D. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood, 2013; 121: 3908-3917","DOI":"10.1182\/blood-2012-10-461798"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Lopez-Romero P. Pre-processing and differential expression analysis of Agilent microRNA arrays using the AgiMicroRna Bioconductor library. BMC genomics, 2011; 12: 64: 1-8","DOI":"10.1186\/1471-2164-12-64"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Ray A and Dittel BN. Isolation of mouse peritoneal cavity cells. J Vis Exp, 2010; 35: e1488: 1-3","DOI":"10.3791\/1488"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Wang L, Shen C, Wang Y, Zou T, Zhu H, Lu X, Li L, Yang B, Chen J, Chen S, Lu X and Gu D. Identification of circular RNA Hsa_circ_0001879 and Hsa_circ_0004104 as novel biomarkers for coronary artery disease. Atherosclerosis, 2019; 286: 88-96","DOI":"10.1016\/j.atherosclerosis.2019.05.006"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Goedeke L, Rotllan N, Canfran-Duque A, Aranda JF, Ramirez CM, Araldi E, Lin CS, Anderson NN, Wagschal A, de Cabo R, Horton JD, Lasuncion MA, Naar AM, Suarez Y and Fernandez-Hernando C. MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels. Nat Med, 2015; 21: 1280-1289","DOI":"10.1038\/nm.3949"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Fu Y, Gao C, Liang Y, Wang M, Huang Y, Ma W, Li T, Jia Y, Yu F, Zhu W, Cui Q, Li Y, Xu Q, Wang X and Kong W. Shift of Macrophage Phenotype Due to Cartilage Oligomeric Matrix Protein Deficiency Drives Atherosclerotic Calcification. Circ Res, 2016; 119: 261-276","DOI":"10.1161\/CIRCRESAHA.115.308021"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Taniguchi K and Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol, 2018; 18: 309-324","DOI":"10.1038\/nri.2017.142"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Aflaki E, Moaven N, Borger DK, Lopez G, Westbroek W, Chae JJ, Marugan J, Patnaik S, Maniwang E, Gonzalez AN and Sidransky E. Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages. Aging Cell, 2016; 15: 77-88","DOI":"10.1111\/acel.12409"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Joseph A DiDonato, Frank Mercurio, Michael Karin.NF-kB and the link between in\ufb02ammation and cancer.Immunol Rev, 2012; 246: 379-400","DOI":"10.1111\/j.1600-065X.2012.01099.x"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Klein-Szanto AJP and Bassi DE. Keep recycling going: New approaches to reduce LDL-C. Biochem Pharmacol, 2019; 164: 336-341","DOI":"10.1016\/j.bcp.2019.04.003"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Wu YR, Shi XY, Ma CY, Zhang Y, Xu RX and Li JJ. Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1\/2 pathway. Cardiovasc Diabetol, 2019; 18: 146: 1-12","DOI":"10.1186\/s12933-019-0954-6"},{"key":"40","unstructured":"40) Schulte C and Zeller T. microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts. Cardiovasc Diagn Ther, 2015; 5: 17-36"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Thanikachalam PV, Ramamurthy S, Wong ZW, Koo BJ, Wong JY, Abdullah MF, Chin YH, Chia CH, Tan JY, Neo WT, Tan BS, Khan WF and Kesharwani P. Current attempts to implement microRNA-based diagnostics and therapy in cardiovascular and metabolic disease: a promising future. Drug Discov Today, 2018; 23: 460-480","DOI":"10.1016\/j.drudis.2017.10.020"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Costantino S, Paneni F, Luscher TF and Cosentino F. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J, 2016; 37: 572-576","DOI":"10.1093\/eurheartj\/ehv599"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Huang S, Chen M, Li L, He M, Hu D, Zhang X, Li J, Tanguay RM, Feng J, Cheng L, Zeng H, Dai X, Deng Q, Hu FB and Wu T. Circulating MicroRNAs and the occurrence of acute myocardial infarction in Chinese populations. Circ Cardiovasc Gene, 2014; 7: 189-198","DOI":"10.1161\/CIRCGENETICS.113.000294"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Zhang R, Qin Y, Zhu G, Li Y and Xue J. Low serum miR-320b expression as a novel indicator of carotid atherosclerosis. J Clin Neurosci, 2016; 33: 252-258","DOI":"10.1016\/j.jocn.2016.03.034"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Xu Y, Xu Y, Zhu Y, Sun H, Juguilon C, Li F, Fan D, Yin L and Zhang Y. Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis. Mol Ther, 2020; 28: 202-216","DOI":"10.1016\/j.ymthe.2019.09.008"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Tsuboi T, Lu R, Yonezawa T, Watanabe A, Woo JT, Abe-Dohmae S and Yokoyama S. Molecular mechanism for nobiletin to enhance ABCA1\/G1 expression in mouse macrophages. Atherosclerosis, 2020; 297: 32-39","DOI":"10.1016\/j.atherosclerosis.2020.01.024"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Aiello RJ, Brees D, Bourassa PA, Royer L, Lindsey S, Coskran T, Haghpassand M and Francone OL. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscl Throm Vas Biol, 2002; 22: 630-637","DOI":"10.1161\/01.ATV.0000014804.35824.DA"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Baldan A, Pei L, Lee R, Tarr P, Tangirala RK, Weinstein MM, Frank J, Li AC, Tontonoz P and Edwards PA. Impaired development of atherosclerosis in hyperlipidemic Ldlr-\/- and ApoE-\/- mice transplanted with Abcg1-\/- bone marrow. Arterioscl Throm Vas Biol, 2006; 26: 2301-2307","DOI":"10.1161\/01.ATV.0000240051.22944.dc"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Ranalletta M, Wang N, Han S, Yvan-Charvet L, Welch C and Tall AR. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-\/- bone marrow. Arterioscl Throm Vas Biol, 2006; 26: 2308-2315","DOI":"10.1161\/01.ATV.0000242275.92915.43"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Out R, Hoekstra M, Hildebrand RB, Kruit JK, Meurs I, Li Z, Kuipers F, Van Berkel TJ and Van Eck M. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscl Throm Vas Biol, 2006; 26: 2295-2300","DOI":"10.1161\/01.ATV.0000237629.29842.4c"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Westerterp M, Bochem AE, Yvan-Charvet L, Murphy AJ, Wang N and Tall AR. ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ Res, 2014; 114: 157-170","DOI":"10.1161\/CIRCRESAHA.114.300738"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Yvan-Charvet L, Ranalletta M, Wang N, Han S, Terasaka N, Li R, Welch C and Tall AR. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest, 2007; 117: 3900-3908","DOI":"10.1172\/JCI33372"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Westerterp M, Murphy AJ, Wang M, Pagler TA, Vengrenyuk Y, Kappus MS, Gorman DJ, Nagareddy PR, Zhu X, Abramowicz S, Parks JS, Welch C, Fisher EA, Wang N, Yvan-Charvet L and Tall AR. Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice. Circ Res, 2013; 112: 1456-1465","DOI":"10.1161\/CIRCRESAHA.113.301086"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Liu YH, Liao LD, Tan SSH, Kwon KY, Ling JM, Bandla A, Shih YI, Tan ETW, Li W, Ng WH, Lai HY, Chen YY and Thakor NV. Assessment of neurovascular dynamics during transient ischemic attack by the novel integration of micro-electrocorticography electrode array with functional photoacoustic microscopy. Neurobiol Dis, 2015; 82: 455-465","DOI":"10.1016\/j.nbd.2015.06.019"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M and Fisher EA. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. P Natl Acad Sci U S A, 2011; 108: 7166-7171","DOI":"10.1073\/pnas.1016086108"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Liljestrand JM, Paju S, Buhlin K, Persson GR, Sarna S, Nieminen MS, Sinisalo J, Mantyla P and Pussinen PJ. Lipopolysaccharide, a possible molecular mediator between periodontitis and coronary artery disease. J Clin Periodontol, 2017; 44: 784-792","DOI":"10.1111\/jcpe.12751"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Moludi J, Maleki V, Jafari-Vayghyan H, Vaghef-Mehrabany E and Alizadeh M. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics. Clin Exp Pharmacol Physiol, 2020; 47: 927-939","DOI":"10.1111\/1440-1681.13250"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Hartley A, Haskard D and Khamis R. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy. Trends Cardiovasc Med, 2019; 29: 22-26","DOI":"10.1016\/j.tcm.2018.05.010"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Zhou Y, Chen R, Liu D, Wu C, Guo P and Lin W. Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE(-\/-) Mice. Mar Drugs, 2017; 15: 1-12","DOI":"10.3390\/md15110358"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Sato Y, Watanabe R, Uchiyama N, Ozawa N, Takahashi Y, Shirai R, Sato K, Mori Y, Matsuyama T, Ishibashi-Ueda H, Hirano T and Watanabe T. Inhibitory effects of vasostatin-1 against atherogenesis. Clin Sci (Lond), 2018; 132: 2493-2507","DOI":"10.1042\/CS20180451"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/2\/29_57125\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T04:01:32Z","timestamp":1644033692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/2\/29_57125\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.57125","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"article-number":"57125"}}